Summit Therapeutics, Inc. (SMMT)
17.90
+2.05
(+12.93%)
USD |
NASDAQ |
May 20, 16:00
17.93
+0.03
(+0.17%)
After-Hours: 05:27
Summit Therapeutics Total Liabilities (Quarterly) : 101.92M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Revolution Medicines, Inc. | 753.82M |
| BioMarin Pharmaceutical, Inc. | 2.379B |
| Relay Therapeutics, Inc. | 57.43M |
| Alnylam Pharmaceuticals, Inc. | 4.054B |
| Amgen, Inc. | 83.31B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 647.86M |
| Shareholders Equity (Quarterly) | 545.93M |
| Debt to Equity Ratio | 0.0367 |
| Current Ratio | 7.405 |
| Net Debt Paydown Yield | -0.02% |